Actuate Therapeutics, Inc. (ACTU) - Uzoq muddatli qarzning kapitalga nisbati
Actuate Therapeutics, Inc. (ACTU) AQSHdagi o'z laboratoriya markazida faoliyat yuritadi, dori sintezi esa ta'minot barqarorligini ta'minlash uchun tashqi pudratchilarga topshirilgan. Ushbu narxlar grafigi jarayonni vizuallashtiradi, bunda ko'rsatkich 0.40 darajasida turibdi. Biznes muvaffaqiyati klinik sinovlarga ishtirokchilarni jalb qilish sur'atlari va kapitalga kirish imkoniyatiga bog'liq. Kompaniyaning progressiv imidji shifokorlar orasida sezilarli ishonchni uyg'otadi.
%20Uzoq%20muddatli%20qarzning%20o'z%20kapitaliga%20nisbati&width=1200&height=400&colorIndex=0&v=mvx9zauv.4e-7b561vk&start=20220704&end=20261101&filename=GURU_Markets_-_ACTU_-_Actuate-Therapeutics-Inc._-_Long-Term-Debt-to-Equity "actuatetherapeutics.com (ACTU): Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi 14.08.2024dan 01.11.2026gacha | 👁️GURU.Markets👁️")
Actuate Therapeutics, Inc. kompaniyasining tahliliy kesimlari
- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi ko'rsatkichlari:
- kompaniyaning balans qiymati tafsilotlari:
- kompaniyaning majburiyatlari va likvidligi ma'lumotlari:
Qarzning kapitalga nisbati Actuate Therapeutics, Inc.|ACTU - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati actuatetherapeutics.com|ACTU - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Actuate Therapeutics, Inc.|ACTU - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Actuate Therapeutics|Tezkor likvidlik koeffitsiyenti actuatetherapeutics.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
Kompaniyaning umumiy tahlili:Actuate Therapeutics Inc. - ACTU
Actuate Therapeutics, Inc. (ACTU) kompaniyasining o'simtaga qarshi dori portfelini diversifikatsiya qilish katta resurslarni talab qiladi, bu esa biznes barqarorligi uchun uzoq muddatli majburiyatlarni boshqarishni muhim qiladi. Ushbu ko'rsatkich kapitalga nisbatan muddati bir yildan ortiq bo'lgan qarz mablag'larining ulushini o'lchaydi, bu esa moliyaviy leverajni va kreditorlarga bog'liqlik xavfini baholash imkonini beradi. Optimal leveraj balansi to'lov qobiliyatiga putur yetkazmagan holda R&D ishlanmalarini rivojlantirishni ta'minlaydi, bu esa tarixiy uzoq muddatli qarzlarning kapitalga nisbati ko'rsatkichida yaqqol aks etgan.
Muhim raqobatchilar
Uzoq muddatli qarzning o'z kapitaliga nisbati BeiGene Ltd. (ONC)|Uzoq muddatli qarzning kapitalga nisbati HALO|Uzoq muddatli qarzning kapitalga nisbati Revolution Medicines Corp (RVMD)|Uzoq muddatli qarzning o'z kapitaliga nisbati Ascentage Pharma Group AAPG|CGON: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|UroGen Pharma - Uzoq muddatli qarzning kapitalga nisbati|Bicara Therapeutics Inc (BCAX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|PSNL: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Erasca Oncology (ERAS)|Uzoq muddatli qarzning o'z kapitaliga nisbati Delcath Systems, Inc.|YMAB: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati AURA (Aura Biosciences)|CADL (candeltx.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ARAY (Accuray Inc.)|SLS - Uzoq muddatli qarzning o'z kapitaliga nisbati|CTOR: Uzoq muddatli qarzning o'z kapitaliga nisbati|HURA - Uzoq muddatli qarzning kapitalga nisbati|Protara Therapeutics, Inc. (TARA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Fate Therapeutics Inc - Uzoq muddatli qarzning kapitalga koeffitsiyenti|WHWK (Aadi Bioscience, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati TScan TCRX|Uzoq muddatli qarzning kapitalga nisbati CSBR|Uzoq muddatli qarzning kapitalga nisbati xbiotech.com (XBIT)|Uzoq muddatli qarzning kapitalga nisbati CVM (CEL-SCI)|OSTX - Uzoq muddatli qarzning o'z kapitaliga nisbati|RADX: Uzoq muddatli qarzning o'z kapitaliga nisbati|Artiva Biotherapeutics, Inc. - Uzoq muddatli kreditlarning kapitalga nisbati|ANL (adlainortye.com) - Uzoq muddatli qarzning o'z kapitaliga nisbati|verupharma.com (VERU) - Uzoq muddatli qarzning kapitalga nisbati|TPST (Tempest Therapeutics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati Xilio|Uzoq muddatli qarzning o'z kapitaliga nisbati RENB (Renovaro Inc.)|Uzoq muddatli kreditlarning kapitalga nisbati MURA|Uzoq muddatli qarzning kapitalga nisbati KAPA (Kairos Pharma)|OnKure Therapeutics, Inc. (OKUR) - Uzoq muddatli majburiyatlarning kapitalga nisbati|GDTC: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti CRIS (Curis, Inc.)|APLM (apollomicsinc.com) - Uzoq muddatli qarzning o'z kapitaliga nisbati|THAR: Uzoq muddatli kreditlarning kapitalga nisbati|ADVB (Advanced Biomed Inc.) - Uzoq muddatli qarzning kapitalga nisbati|GNPX: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati CLDI|SBFM - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Xenetic Biosciences, Inc. XBIO|Uzoq muddatli qarzning kapitalga koeffitsiyenti SLRX|Purple Biotech - Uzoq muddatli qarzning kapitalga nisbati|AONC - Uzoq muddatli qarzning kapitalga nisbati|BeiGene (BGNE) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati CKPT (Checkpoint Therapeutics Inc.)|ELEV (Elevation Oncology, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati iCAD Corp ICAD|Uzoq muddatli qarzning o'z kapitaliga nisbati IKNA (Ikena Oncology, Inc.)|Uzoq muddatli qarzning kapitalga nisbati notablelabs.com (NTBL)|Viracta Therapeutics, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli kreditlarning kapitalga nisbati MOR (MorphoSys Inc)|NAYA Bio - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Ascentage AAPGV